Teva Announces Favorable Court Ruling in COPAXONE® Patent Infringement Litigation
02:28 EDT 23 Jun 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today the
U.S. District Court for the Southern District of New York has found in
favor of Teva in the Company’s patent infringement lawsuit against
Momenta Pharmaceuti...
Other Sources for this Article
Teva Pharmaceutical Industries Ltd.
IR:
United States
Kevin
C. Mannix, 215-591-8912
or
PR:
United States
Denise
Bradley, 215-591-8974
or
Israel
Shir Altay-Hagoel,
972-3-926-7590
More From BioPortfolio on "Teva Announces Favorable Court Ruling in COPAXONE® Patent Infringement Litigation"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
